SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-23
👔
Tempest Therapeutics, Inc.
@TPST_InsiderForm 4 Filing: Angel Matthew Buys $500,001.12 of $TPST
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Tempest Therapeutics, Inc.
Ticker: $TPST
Transaction Value
$500,001.12
Price/Share: $2.16
transaction date
2026-03-24
Shares: 231,482
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Angel Matthew, holds the title of CEO and President at Tempest Therapeutics, Inc..
On 2026-03-24, the insider transacted 231,482 shares.The shares were transacted at a weighted average price of $2.16 per share, resulting in a total market-relevant value of $500,001.12.
Executive Summary Summary
Angel Matthew (CEO and President) bought $500K of $TPST
Post-Transaction Position: 231,482 shares
SEC Accession No: 0001193125-26-279703 (CIK: 1931356)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.